Eight Dragons Appoints Martin Schmieg as CFO

4/26/17

Eight Dragons Co. (OTC: EDRG) announced today the appointment of Martin Schmieg as Chief Financial Officer. Mr. Schmieg will be responsible for the management and oversight of Eight Dragons' financial analysis, planning and reporting.

"We are pleased to welcome Martin to Eight Dragons," said Una Taylor, Chairman and CEO of Eight Dragons. "His experience and expertise in finance at the senior-most levels are critical to ensuring that we can deliver the highest standard in our financial operations and reporting for our portfolio companies and shareholders. We want to build a senior leadership team from the best talent in the industry and Martin serves as a clear example of the commitment."

Mr. Schmieg is a seasoned executive with 35 years of financial and executive-level experience, with much of that time in CFO roles in the global biotech, med-tech and pharmaceutical industries. In 2006, he was CEO of Freedom-2, Inc., where he led the company in the development and market introduction of InfinitInk, which was a Time Magazine "Invention of the Year" in 2008.

"Eight Dragons has recognized that venture is a much more mature asset class today and is building something truly new," said Mr. Schmieg. "We intend to expand significantly the participation in venture and bring a new level of transparency to venture investing. I look forward to working alongside this great team to deliver that."

About Eight Dragons

Eight Dragons (OTC: EDRG) is a technology-investment firm that invests in and operates companies to support a full-stack development ecosystem for start-ups. Headquartered in Miami, FL and commencing operations in 2017, Eight Dragons seeks to help companies using innovation and vision to address the world's biggest challenges and realize exponential opportunities. The firm trades on the OTC market under ticker symbol EDRG. For more information, please visit www.edrg.com, or follow us on Twitter at @edrgco.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.